Hannah Furfaro is a mental health reporter at The Seattle Times. She spent the first half of her career covering education; for the past several years, she has covered science and health. She is a 2022-23 Carter Center for Mental Health Journalism fellow. Her stories have appeared in The Atlantic, Science, Scientific American, and The Wall Street Journal, among other publications. Furfaro’s work has been recognized as a finalist and winner of several national and regional awards. In 2021, her investigation of a common antipsychotic called Abilify was a finalist for the National Institute of Health Care Management award. In 2019, her piece about a cluster of people with a rare genetic condition in Colombia was recognized as a finalist for a Deadline Club award and was included in The Best American Science and Nature Writing. She has a master’s degree in science and health journalism from Columbia University and an undergraduate degree from the University of Wisconsin-Madison. She is a committee member of the Association of Health Care Journalists and a member of the Northwest Science Writers Association.